To verify the inhibitory effect on FOXM1, we treated patient-derived pre-B ALL cells with ARF26–44 and control peptide and analysed FOXM1 target gene transcription by qRT–PCR. The gene discussed is FOXM1; the disease is acute lymphoblastic leukemia.